Metabolic programs define dysfunctional immune responses in severe COVID-19 patients
Elizabeth A. Thompson(North Carolina State University), Jonathan D. Powell(Enzo Life Sciences (United States)), Richard E. Rothman(Rush University Medical Center), Hongkai Ji(Johns Hopkins University), Weiqiang Zhou(Johns Hopkins University), Evan M. Bloch(Johns Hopkins University), Alvaro A. Ordoñez(Johns Hopkins University), Avi Z. Rosenberg(Johns Hopkins University), Nathan Brady(St. James's Hospital), Ajay Vaghasia(Sidney Kimmel Comprehensive Cancer Center), Franco R. D’Alessio(University of Maryland, Baltimore), Michael J. Delannoy(Johns Hopkins University), Im‐Hong Sun(University of California, San Francisco), Andrew Pekosz(Johns Hopkins University), Aaron A.R. Tobian(Johns Hopkins University), Anne Hamacher‐Brady(Johns Hopkins University), Kellie N. Smith(Bloomberg (United States)), Srinivasan Yegnasubramanian(Johns Hopkins University), Andrew D. Redd(Johns Hopkins University), Andrea L. Cox(Johns Hopkins University), Rulin Wang(Sidney Kimmel Comprehensive Cancer Center), Maureen Horton(Johns Hopkins University), Katherine Fenstermacher(Johns Hopkins University), Lauren Sauer(Johns Hopkins University), Katherine Cascino(Johns Hopkins University)
Cited by 135
Related Papers
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
|New England Journal of Medicine|2018|2.1k
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
|Biology of Blood and Marrow Transplantation|2008|1.9k
Clinical Practice Guidelines From the AABB
|JAMA|2016|1.1k